Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted N-heterocyclic compounds and their use as dopamine D3 receptor ligands

Substituted N-heterocyclic compounds and their use as dopamine D3 receptor ligands

US Patent 8114875 · Granted Feb 14, 2012

Estimated economic value: $29,968,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthesis of novel ketone body analogs for use as a nutritional supplement2023
Fused heterocyclic compounds as S1P modulators2020
Inhibitor compounds of phosphodiesterase type 10A2019
Fused (hetero)cyclic compounds as S1P modulators2019
Quinoline compounds suitable for treating disorders that respond to the modulati2018
Inhibitor compounds of phosphodiesterase type 10A2018
Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substitu2018
Inhibitor compounds of phosphodiesterase type 10A2018
Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and2017
Inhibitor compounds of phosphodiesterase type 10A2017
Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof f2017
Oxindole derivatives carrying an oxetane substituent and use thereof for treatin2017